Paper40697997
Lipoprotein(a) as an early marker of cardiovascular events in high-risk subjects: insights from the Moli-sani cohort study.
Gianfagna F and 15 others. Front Cardiovasc Med, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Lipoprotein(a) as an early marker of cardiovascular events in high-risk subjects: insights from the Moli-sani cohort study. Papers, record 40697997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40697997
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lipoprotein(a) as an early marker of cardiovascular events in high-risk subjects: insights from the Moli-sani cohort study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15188938 | Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis. | Clin Cardiol | 2004 | https://conductscience.org/library/papers/15188938 | PubMed |
| 2 | 2476992 | Transient changes of serum lipoprotein(a) as an acute phase protein. | Atherosclerosis | 1989 | https://conductscience.org/library/papers/2476992 | PubMed |
| 3 | 12633762 | Evaluation of a fully-automated particle-enhanced turbidimetric immunoassay for the measurement of plasma lipoprotein(a). population-based reference values in an area with low incidence of cardiovascular disease. | Clin Biochem | 2003 | https://conductscience.org/library/papers/12633762 | PubMed |
| 4 | 28183512 | A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies. | J Am Coll Cardiol | 2017 | https://conductscience.org/library/papers/28183512 | PubMed |
| 5 | 35606072 | Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill? | Atherosclerosis | 2022 | https://conductscience.org/library/papers/35606072 | PubMed |
| 6 | 39219855 | Intra-individual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate risk. | Eur Heart J Open | 2024 | https://conductscience.org/library/papers/39219855 | PubMed |
| 7 | 16000355 | Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. | N Engl J Med | 2005 | https://conductscience.org/library/papers/16000355 | PubMed |
| 8 | 39018080 | Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis. | JAMA Cardiol | 2024 | https://conductscience.org/library/papers/39018080 | PubMed |
| 9 | 9799757 | Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. | Clin Chem | 1998 | https://conductscience.org/library/papers/9799757 | PubMed |
| 10 | 30316749 | Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisal. | J Clin Lipidol | 2018 | https://conductscience.org/library/papers/30316749 | PubMed |
| 11 | 36764050 | Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses. | Atherosclerosis | 2023 | https://conductscience.org/library/papers/36764050 | PubMed |
| 12 | 7660402 | Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study. | Stroke | 1995 | https://conductscience.org/library/papers/7660402 | PubMed |
| 13 | 20032323 | Genetic variants associated with Lp(a) lipoprotein level and coronary disease. | N Engl J Med | 2009 | https://conductscience.org/library/papers/20032323 | PubMed |
| 14 | 30527993 | Interaction between Mediterranean diet and statins on mortality risk in patients with cardiovascular disease: Findings from the Moli-sani Study. | Int J Cardiol | 2019 | https://conductscience.org/library/papers/30527993 | PubMed |
| 15 | 27677946 | Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology. | J Lipid Res | 2016 | https://conductscience.org/library/papers/27677946 | PubMed |
| 16 | 12826634 | Adherence to a Mediterranean diet and survival in a Greek population. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12826634 | PubMed |
| 17 | 23973688 | Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes). | J Am Coll Cardiol | 2013 | https://conductscience.org/library/papers/23973688 | PubMed |
| 18 | 38240386 | C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project. | Eur Heart J | 2024 | https://conductscience.org/library/papers/38240386 | PubMed |
| 19 | 36770634 | Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment. | Molecules | 2023 | https://conductscience.org/library/papers/36770634 | PubMed |
| 20 | 22898069 | Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies. | J Am Coll Cardiol | 2012 | https://conductscience.org/library/papers/22898069 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42780648 | Identifying barriers to lipoprotein(a) testing in secondary cardiovascular prevention and co-designing implementation strategies: an Italian behavior change wheel-informed study. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42780648 | PubMed |
| 42764843 | Lipoprotein(a) as a Predictor of Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Cohort Studies (2016-2026). | Cureus | 2026 | https://conductscience.org/library/papers/42764843 | PubMed |
| 42643372 | Lipoprotein(a) in cardiovascular disease: pathophysiology, residual risk, and emerging therapeutic strategies. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42643372 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| LPA | 4018 | PubTator's text mining | https://conductscience.org/library/genes/4018 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40697997
GET https://conductscience.org/api/papers/v1/40697997/references?page=2